Some studies have reported that an increased level of APOE2 protein in the brain contributes to increased tau aggregation and behavioral impairment, and that APOE2 is positively correlated with the severity of tau pathology in patients with PSP [102, 104]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.